Mifepristone 50 mg as a Contraceptive

  Women on Web                 Georgia

Women on Web International Foundation’s innovation is a non-inferiority clinical trial in Georgia, comparing the contraceptive use of weekly mifepristone with the daily use of desogestrel, an alternative non-estrogen contraceptive. The trial aims to establish the efficacy, safety and side-effects of mifepristone as a weekly contraceptive. The long-term goal of the innovation is to register and market mifepristone as a contraceptive and to have this indication included on the World Health Organization Essential Medicines List.